跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 244 条关于
“PTT101”
全部
244
临床试验
180
药物
42
机构
0
资讯
22
去年
Pentixapharm Pivots Clinical Strategy to Focus on CXCR4-Targeted Theranostic Oncology Platform
2年前
Tempo Therapeutics Initiates Clinical Trial of TT101 for Tissue Repair in Skin Cancer Surgery
3年前
FDA Accepts Satsuma Pharmaceuticals' NDA for STS101 Migraine Treatment
去年
FDA Rejects Satsuma's STS101 Nasal Migraine Treatment Citing Manufacturing Issues
3年前
Ropeginterferon Alfa-2b Shows Promise in Hydroxyurea-Resistant Essential Thrombocythemia
去年
Allay Therapeutics' ATX101 Receives FDA Breakthrough Therapy Designation for Post-Surgical Pain Relief After Total Knee Arthroplasty
去年
FDA Accepts Satsuma and SNBL's NDA Resubmission for STS101 Migraine Treatment
去年
Encoded Therapeutics Receives FDA RMAT Designation for ETX101 Gene Therapy in Dravet Syndrome
9个月前
Encoded Therapeutics Reports 78% Seizure Reduction with ETX101 Gene Therapy in Dravet Syndrome Trial
去年
Phase 2 Trial Initiates for Personalized Immunotherapy FK-PC101 in High-Risk Prostate Cancer
第 1 页,共 3 页
上一页
下一页